These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25016226)

  • 21. Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy.
    Ochoa MC; Fioravanti J; Duitman EH; Medina-Echeverz J; Palazon A; Arina A; Dubrot J; Alfaro C; Morales-Kastresana A; Murillo O; Hervas-Stubbs S; Prieto J; Berraondo P; Melero I
    PLoS One; 2012; 7(12):e52370. PubMed ID: 23285013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
    Conlon KC; Lugli E; Welles HC; Rosenberg SA; Fojo AT; Morris JC; Fleisher TA; Dubois SP; Perera LP; Stewart DM; Goldman CK; Bryant BR; Decker JM; Chen J; Worthy TA; Figg WD; Peer CJ; Sneller MC; Lane HC; Yovandich JL; Creekmore SP; Roederer M; Waldmann TA
    J Clin Oncol; 2015 Jan; 33(1):74-82. PubMed ID: 25403209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.
    Macgregor JN; Li Q; Chang AE; Braun TM; Hughes DP; McDonagh KT
    Cancer Res; 2006 May; 66(9):4913-21. PubMed ID: 16651448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression.
    Miller G; Bleier JI; Antonescu C; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
    Int J Cancer; 2004 Jun; 110(3):395-402. PubMed ID: 15095305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
    Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
    J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.
    Xiang R; Lode HN; Dolman CS; Dreier T; Varki NM; Qian X; Lo KM; Lan Y; Super M; Gillies SD; Reisfeld RA
    Cancer Res; 1997 Nov; 57(21):4948-55. PubMed ID: 9354462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.
    Vogt A; Sievers E; Lukacs-Kornek V; Decker G; Raskopf E; Meumann N; Büning H; Sauerbruch T; Strassburg CP; Schmidt-Wolf IG; Gonzalez-Carmona MA
    Liver Int; 2014 Mar; 34(3):447-61. PubMed ID: 23998316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of NK and CD8
    White EJ; Trigatti BL; Igdoura SA
    J Neuroimmunol; 2017 May; 306():55-67. PubMed ID: 28385189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8
    Puca E; Probst P; Stringhini M; Murer P; Pellegrini G; Cazzamalli S; Hutmacher C; Gouyou B; Wulhfard S; Matasci M; Villa A; Neri D
    Int J Cancer; 2020 May; 146(9):2518-2530. PubMed ID: 31374124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
    Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
    Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice.
    Anzai R; Seki S; Ogasawara K; Hashimoto W; Sugiura K; Sato M; Kumagai K; Takeda K
    Immunology; 1996 May; 88(1):82-9. PubMed ID: 8707355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour-infiltrating bystander CD8
    Leem G; Jeon M; Kim KW; Jeong S; Choi SJ; Lee YJ; Kim ES; Lee JI; Ha SY; Park SH; Shim HS; Lee JG; Kang SM; Shin EC
    Thorax; 2022 Aug; 77(8):769-780. PubMed ID: 34853159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses.
    Earl PL; Americo JL; Moss B
    PLoS Pathog; 2020 Apr; 16(4):e1008505. PubMed ID: 32320436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.